Abstract
HDL mimetics have been constructed from a number of peptides and proteins with varying structures, all of which bind lipids found in HDL. HDL mimetics containing a peptide or protein have been constructed with as few as 4 and as many as 243 amino acid residues. Some HDL mimetics have been constructed with lipid but without a peptide or protein component. Some HDL mimetics promote cholesterol efflux, some have been shown to have a remarkable ability to bind oxidized lipids compared to human apolipoprotein A-I (apoA-I). Many of these peptides have been shown to have antiinflammatory properties. Based on studies in a number of animal models and in early human clinical trials, HDL mimetics appear to have promise as diagnostic and therapeutic agents.
MeSH terms
-
Administration, Oral
-
Animals
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / chemistry
-
Anti-Inflammatory Agents / metabolism
-
Anti-Inflammatory Agents / pharmacology*
-
Apolipoprotein A-I / metabolism
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / metabolism
-
Cholesterol / metabolism
-
Humans
-
Hypolipidemic Agents / administration & dosage
-
Hypolipidemic Agents / chemistry
-
Hypolipidemic Agents / metabolism
-
Hypolipidemic Agents / pharmacology*
-
Lipoproteins, HDL / chemistry
-
Lipoproteins, HDL / metabolism*
-
Molecular Mimicry*
-
Oxidation-Reduction
-
Peptides / administration & dosage
-
Peptides / chemistry
-
Peptides / metabolism
-
Peptides / pharmacology*
-
Protein Binding
-
Protein Conformation
-
Structure-Activity Relationship
Substances
-
APOA1 protein, human
-
Anti-Inflammatory Agents
-
Apolipoprotein A-I
-
Hypolipidemic Agents
-
Lipoproteins, HDL
-
Peptides
-
Cholesterol